| Financial Year |
March 31 2023 |
| Monetary Funds |
196,767,392.29 |
| Held-for-trading Financial Assets |
60,776,583.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
181,017,876.19 |
| Advances to Suppliers |
8,963,844.84 |
| Other Receivables |
3,652,993.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
664,479,379.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,161,723.57 |
| Total Current Assets |
1,120,819,793.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,368,379.11 |
| Investment Properties |
-- |
| Fixed Assetes |
38,941,187.37 |
| Under-construction Projects |
46,551,980.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,123,895.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,345,799.64 |
| Deferred Income Tax Assets |
9,648,817.09 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
171,449,646.44 |
| Total Assets |
1,292,269,439.59 |
| Short-Term Loans |
354,160,708.61 |
| Trading Financial liabilities |
2,725,401.33 |
| Notes Payable |
98,017,000.00 |
| Accounts Payable |
179,486,900.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,198,703.24 |
| Taxes Payable |
18,906,899.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,289,700.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,960,402.97 |
| Other Current Liabilities |
1,187,463.16 |
| Sub-Total of Current Liabilities |
696,119,701.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
620,522.94 |
| Deferred Income Tax Liabilities |
2,006,817.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,224,729.87 |
| Total Liabilities |
729,344,431.84 |
| Paid-In Capital(Or Share Stock) |
66,690,000.00 |
| Capital Surplus |
229,286,758.05 |
| Surplus Reserve |
58,141,050.71 |
| LESS:Treasury Stock |
15,090,592.00 |
| Undistributed Profits |
223,897,790.99 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
562,925,007.75 |
| Owner's Equity（Stockholder's Equity） |
562,925,007.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,292,269,439.59 |
